Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

More articles from Minireview

  • You have access
    Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds
    Yanfang Yang, Zijing Xia, Xixi Wang, Xinyu Zhao, Zenghua Sheng, Yang Ye, Gu He, Liangxue Zhou, Hongxia Zhu, Ningzhi Xu and Shufang Liang
    Molecular Pharmacology August 2018, 94 (2) 885-894; DOI: https://doi.org/10.1124/mol.118.112300
  • Open Access
    PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis
    Qiao Yi Chen and Max Costa
    Molecular Pharmacology July 2018, 94 (1) 784-792; DOI: https://doi.org/10.1124/mol.118.112268
  • You have access
    N-Acyl Amino Acids (Elmiric Acids): Endogenous Signaling Molecules with Therapeutic Potential
    Sumner H. Burstein
    Molecular Pharmacology March 2018, 93 (3) 228-238; DOI: https://doi.org/10.1124/mol.117.110841
  • You have access
    PXR: More Than Just a Master Xenobiotic Receptor
    Peter O. Oladimeji and Taosheng Chen
    Molecular Pharmacology February 2018, 93 (2) 119-127; DOI: https://doi.org/10.1124/mol.117.110155
  • You have access
    Notch Signaling: Linking Embryonic Lung Development and Asthmatic Airway Remodeling
    Musaddique Hussain, Chengyun Xu, Mashaal Ahmad, Youping Yang, Meiping Lu, Xiling Wu, Lanfang Tang and Ximei Wu
    Molecular Pharmacology December 2017, 92 (6) 676-693; DOI: https://doi.org/10.1124/mol.117.110254
  • You have access
    A Scale of Agonism and Allosteric Modulation for Assessment of Selectivity, Bias, and Receptor Mutation
    Terry Kenakin
    Molecular Pharmacology October 2017, 92 (4) 414-424; DOI: https://doi.org/10.1124/mol.117.108787
  • You have access
    The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs
    Mario Rossi, Irene Fasciani, Francesco Marampon, Roberto Maggio and Marco Scarselli
    Molecular Pharmacology June 2017, 91 (6) 586-594; DOI: https://doi.org/10.1124/mol.116.107607
  • You have access
    Developmental, Genetic, Dietary, and Xenobiotic Influences on Neonatal Hyperbilirubinemia
    Mei-Fei Yueh, Shujuan Chen, Nghia Nguyen and Robert H. Tukey
    Molecular Pharmacology May 2017, 91 (5) 545-553; DOI: https://doi.org/10.1124/mol.116.107524
  • You have access
    Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention
    Daniel F. Legler, Christoph Matti, Julia M. Laufer, Barbara D. Jakobs, Vladimir Purvanov, Edith Uetz-von Allmen and Marcus Thelen
    Molecular Pharmacology April 2017, 91 (4) 331-338; DOI: https://doi.org/10.1124/mol.116.107151
  • You have access
    G-Protein–Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer
    Laura Nogués, Clara Reglero, Verónica Rivas, María Neves, Petronila Penela and Federico Mayor
    Molecular Pharmacology March 2017, 91 (3) 220-228; DOI: https://doi.org/10.1124/mol.116.107185

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics